Paul Mitchell is an Investor at Alyeska Investment Group, whose known portfolio counts 4 companies.
Is Paul Mitchell a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Stage
- Late-Stage
Contacts
Affiliated funds' portfolios
Investor at Alyeska Investment Group, whose known portfolio counts 4 companies
- I-Mab Biopharma
- Gemini Therapeutics
- Fulcrum Therapeutics
- Nautilus Biotechnology
Investor Profile
Stage-wise, the deals at Alyeska Investment Group cluster around Late-Stage rounds.
The firm portfolio and the focus above give founders context on whether Paul Mitchell matches their raise.
Colleagues at Alyeska Investment Group
Frequently asked questions
Who is Paul Mitchell?
Paul Mitchell is a venture debt investor based in Chicago, Illinois, United States, listed as Investor at Alyeska Investment Group. The known portfolio of that firm counts 4 companies. That portfolio belongs to the firm, not to Paul Mitchell personally.
What stage does Paul Mitchell invest at?
Alyeska Investment Group appears in Late-Stage rounds across its known deals, and Paul Mitchell is listed there as Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Paul Mitchell listed at?
Paul Mitchell is listed as Investor at Alyeska Investment Group. 2 other people in the database share a firm with Paul Mitchell.
How do I contact Paul Mitchell?
A LinkedIn page is on file for Paul Mitchell. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal